Discover why high blood pressure earned its "silent killer" nickname, how it damages organs without symptoms, and the ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced positive topline results from its pivotal Launch-HTN Phase 3 and ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Researchers at Monash University have uncovered how the gut—and the food we eat—affects high blood pressure. Their discovery ...

Persistent high blood pressure occurs when patients have multiple elevated blood pressure readings over time, even while ...

Discover the five critical stages of hypertension from normal to high crisis, learn warning signs, and find out when you need ...

In the U.S., 1 in 3 adults is at risk for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and excess body weight. This cluster of conditions ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and resistant hypertension.

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood ...

Mineralys Therapeutics on Monday reported positive topline results from a pair of pivotal studies of its lorundrostat drug candidate for the treatment of uncontrolled or resistant hypertension.

Albany Medical Center is now offering a new procedure aimed at helping patients with resistant hypertension, a condition ...

Implementing the ventilator-associated events (VAE) prevention protocol at Community Health Network has yielded remarkable ...